The Pennant Group, Inc.
NASDAQThe Pennant Group has had an eventful week — a blowout Q1 print drove the stock up 13%, analysts lifted targets across the board, and short sellers retreated sharply. Then, on Wednesday, the Centers for Medicare & Medicaid Services announced six-month moratoria on new hospice and home health agency registrations, citing fraud prevention. That headline landed just as the…
Snapshot as of 22 Jun 2026
The Pennant Group has had an eventful week — a blowout Q1 print drove the stock up 13%, analysts lifted targets across the board, and short sellers retreated sharply. Then, on Wednesday, the Centers for Medicare &…
PNTG heads into its Q1 2026 print with a market that has been decisively re-rating the stock higher — and analysts chasing it. The setup is one of quiet confidence rather than defensive hedging. Short interest is…
The Pennant Group enters the post-earnings session with a clean beat on both the top and bottom line — and a short base that has been quietly shrinking for weeks. Q1 2026 results, released on May 6, showed adjusted EPS…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PNTG — free to start on ORTEX.
Sign up for free →Open PNTG on ORTEX